Bliss GVS Pharma Ltd gets confirmation of WHO-GMP Compliance of Manufacturing Facility

Bliss GVS Pharma Limited's manufacturing facility located at Survey No. 43 & 44, Vevoor Village, Palghar (East), Dist.- Palghar, 401404, Maharashtra, India, has received an Inspection Closure Report from the World Health Organization (WHO), Geneva, Switzerland, wherein the facility has been confirmed to be in compliance with the Good Manufacturing Practices (GMP) standards published by the WHO.

This achievement reflects the Company's commitment to quality assurance, safety and operational excellence in its manufacturing processes.

Shares of Bliss GVS Pharma Limited was last trading in BSE at Rs. 439.40 as compared to the previous close of Rs. 434.75. The total number of shares traded during the day was 194739 in over 3700 trades.

The stock hit an intraday high of Rs. 447.35 and intraday low of 429.25. The net turnover during the day was Rs. 85608078.00.

Source : Equity Bulls

Keywords

BlissGVSPharma INE416D01022 Pharmaceuticals